NCT02243748View on ClinicalTrials.gov

Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers

NACompletedINTERVENTIONAL
Enrollment

361

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 30, 2019

Study Completion Date

April 22, 2019

Conditions
CaregiverPsychological Impact of Cancer and Its TreatmentRecurrent Non-small Cell Lung CancerStage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Interventions
OTHER

Palliative Therapy

Receive individualized palliative care

OTHER

quality-of-life assessment

Ancillary studies

OTHER

questionnaire administration

Ancillary studies

Trial Locations (5)

91010

City of Hope Medical Center, Duarte

91101

Kaiser Permanente Department of Research and Evaluation, Pasadena

91761

Kaiser Permanente-Ontario Vineyard Medical Offices and Ambulatory SurgiCenter, Ontario

92505

Kaiser Permanente Medical Center, Riverside

92618

Southern California Permanente Medical Group, Irvine

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Institute of Nursing Research (NINR)

NIH

lead

City of Hope Medical Center

OTHER

NCT02243748 - Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers | Biotech Hunter | Biotech Hunter